CA945990A - Substituted 3-amino-4-halogen-sydnonimines - Google Patents

Substituted 3-amino-4-halogen-sydnonimines

Info

Publication number
CA945990A
CA945990A CA046,827A CA46827A CA945990A CA 945990 A CA945990 A CA 945990A CA 46827 A CA46827 A CA 46827A CA 945990 A CA945990 A CA 945990A
Authority
CA
Canada
Prior art keywords
sydnonimines
halogen
amino
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA046,827A
Other languages
English (en)
Inventor
Kurt Freter
Karl Zeile
Manfred Gotz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim GmbH
Original Assignee
Boehringer Ingelheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim GmbH filed Critical Boehringer Ingelheim GmbH
Application granted granted Critical
Publication of CA945990A publication Critical patent/CA945990A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/04—1,2,3-Oxadiazoles; Hydrogenated 1,2,3-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA046,827A 1968-03-26 1969-03-26 Substituted 3-amino-4-halogen-sydnonimines Expired CA945990A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19681770061 DE1770061A1 (de) 1968-03-26 1968-03-26 Neue substituierte 3-Amino-4-bromsydnomimine

Publications (1)

Publication Number Publication Date
CA945990A true CA945990A (en) 1974-04-23

Family

ID=5700383

Family Applications (1)

Application Number Title Priority Date Filing Date
CA046,827A Expired CA945990A (en) 1968-03-26 1969-03-26 Substituted 3-amino-4-halogen-sydnonimines

Country Status (18)

Country Link
AT (1) AT285619B (es)
BE (1) BE730510A (es)
BG (1) BG15220A3 (es)
BR (1) BR6907417D0 (es)
CA (1) CA945990A (es)
CH (1) CH519511A (es)
DE (1) DE1770061A1 (es)
DK (1) DK130296B (es)
ES (2) ES364979A1 (es)
FI (1) FI54480C (es)
FR (1) FR2004770A1 (es)
GB (1) GB1219254A (es)
HU (1) HU162735B (es)
IE (1) IE32708B1 (es)
IL (1) IL31909A (es)
NL (1) NL6904632A (es)
SE (1) SE374746B (es)
YU (1) YU69369A (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2930736A1 (de) 1979-07-28 1981-02-12 Cassella Ag Pharmakologisch wirksame, substituierte 3-amino-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
NL6904632A (es) 1969-09-30
GB1219254A (en) 1971-01-13
DK130296B (da) 1975-02-03
CH519511A (de) 1972-02-29
DE1770061A1 (de) 1971-09-16
IL31909A (en) 1973-01-30
HU162735B (es) 1973-04-28
BR6907417D0 (pt) 1973-04-12
FI54480B (fi) 1978-08-31
IE32708B1 (en) 1973-10-31
YU69369A (en) 1978-09-18
FR2004770A1 (es) 1969-11-28
SE374746B (es) 1975-03-17
IE32708L (en) 1969-09-26
DK130296C (es) 1975-06-30
ES364979A1 (es) 1971-02-16
AT285619B (de) 1970-11-10
IL31909A0 (en) 1969-05-28
ES376981A1 (es) 1972-05-01
BE730510A (es) 1969-09-26
BG15220A3 (bg) 1975-11-21
FI54480C (fi) 1978-12-11

Similar Documents

Publication Publication Date Title
AU423886B2 (en) Croplifter
CA945990A (en) Substituted 3-amino-4-halogen-sydnonimines
AU439416B2 (en) Substituted hydroxyphenyl-alkylamines
AU435030B2 (en) Substituted hydro-2-naphthalenone
CA801091A (en) Substituted 2-phenoxycyclopropylamines
CA801095A (en) Substituted cyclohexanemethylamines
CA794850A (en) Substituted 2-oxothiophens
CA801096A (en) Substituted cyclohexanemethylamines
CA780859A (en) Substituted dihydrobenzo-thiadiazines
CA778378A (en) Substituted hydrouracils
CA777726A (en) Substituted hydrouracils
CA784244A (en) Substituted n-phenylalkyl-n-alkylaminoalkyl carbanilates
CA798874A (en) Substituted tetrahydroindoles
AU420728B2 (en) Ketonitriles
AU432563B2 (en) 1-substituted -3-aroyl-pyrrolidines
AU423118B2 (en) 2-imi no-methyleneimines
AU435718B2 (en) Anilinomethylenemalononitriles
AU430041B1 (en) 1 -phanoxy-2-hydroxy-3-alkylaminopropanes
AU430980B2 (en) 1-hydroxy-4keto- -ionone
AU431720B2 (en) Dibenzocyclo-octene-12-methyl-amines
AU432343B2 (en) Pyridobenzodiazepines
AU432545B2 (en) 1 - carbamoyl -3- aroylprolidines
AU429748B2 (en) Steroid-butenolides
AU432835B2 (en) Tachistoscope
AU433034B2 (en) Imidazoisoindolols